September 15, 2017
Dr. Joseph Scandura selected as one of four investigators for a new, multi-institution project launching in 2018: The MPN Interferon Initiative. This research project aims to evaluate how targeting the interferon pathway can be used to treat MPN patients and why this is effectively in only a subset of patients. The MPN Interferon Initiative is a partnership between MPN Research Foundation, Northwestern University and Cancer Research & Treatment Fund (CR&T).
The initial team of investigators includes:
The initial team of investigators includes:
- Leonidas Platanias, MD, PhD: Lurie Cancer Center
- Ann Mullally, MD: Division of Hematology, Brigham and Woman's Hospital
- Jean-Luc Villeval, PhD: INSERM/Institut Gustave Roussy, Paris
- Joseph Scandura, MD, PhD: Weill Cornell School of Medicine
The MPN Research Foundation was founded in 2000 by a group of patients and funds innovative research with the goal of expanding knowledge regarding myeloproliferative neoplasms and ultimately finding cures for this group of diseases.